{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:27:56Z","timestamp":1793946476548,"version":"4.8.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T00:00:00Z","timestamp":1793923200000},"content-version":"vor","delay-in-days":112,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"DOI":"10.1186\/s12889-026-28139-w","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T07:32:46Z","timestamp":1784273566000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluating the impact of the Hepatitis B Foundation\u2019s international storytelling program on empowerment, advocacy, and stigma reduction"],"prefix":"10.1186","volume":"26","author":[{"given":"Michelle","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bright","family":"Ansah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noah M.","family":"Trudeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella B.","family":"Dlamini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anousha","family":"Qureshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmin","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chari","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Freeland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"key":"28139_CR1","unstructured":"World Health Organization, Hepatitis B. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-b. Accessed 13 March 2026."},{"key":"28139_CR2","doi-asserted-by":"publisher","DOI":"10.54394\/CJQU6666","volume-title":"Global hepatitis report 2024: action for access in low- and middle-income countries","author":"World Health Organization","year":"2024","unstructured":"World Health Organization. Global hepatitis report 2024: action for access in low- and middle-income countries. Geneva: World Health Organization; 2024."},{"key":"28139_CR3","volume-title":"Eliminating the public health problem of hepatitis B and C in the United States: phase one report","author":"National Academies of Sciences, Engineering, and Medicine","year":"2016","unstructured":"National Academies of Sciences, Engineering, and Medicine. Eliminating the public health problem of hepatitis B and C in the United States: phase one report. Washington (DC): National Academies; 2016."},{"key":"28139_CR4","volume-title":"Global health sector strategy on viral hepatitis 2016\u20132021","author":"World Health Organization","year":"2016","unstructured":"World Health Organization. Global health sector strategy on viral hepatitis 2016\u20132021. Geneva: World Health Organization; 2016."},{"key":"28139_CR5","volume-title":"A national strategy for the elimination of hepatitis B and C: phase two report","author":"Medicine","year":"2017","unstructured":"National Academies of Sciences, Engineering, and, Medicine. A national strategy for the elimination of hepatitis B and C: phase two report. Washington (DC): National Academies; 2017."},{"issue":"4","key":"28139_CR6","doi-asserted-by":"publisher","first-page":"324","DOI":"10.4103\/2347-5625.195896","volume":"3","author":"H Lee","year":"2016","unstructured":"Lee H, Fawcett J, Kim D, Yang JH. Correlates of hepatitis B virus-related stigmatization experienced by Asians: a scoping review of literature. Asia Pac J Oncol Nurs. 2016;3(4):324\u201334. https:\/\/doi.org\/10.4103\/2347-5625.195896.","journal-title":"Asia Pac J Oncol Nurs"},{"issue":"3","key":"28139_CR7","doi-asserted-by":"publisher","first-page":"398","DOI":"10.3390\/ijerph16030398","volume":"16","author":"TV Le","year":"2019","unstructured":"Le TV, Vu TTM, Mai HT, et al. Social determinants of stigma and discrimination in Vietnamese patients with chronic hepatitis B. Int J Environ Res Public Health. 2019;16(3):398. https:\/\/doi.org\/10.3390\/ijerph16030398.","journal-title":"Int J Environ Res Public Health"},{"issue":"Suppl 4","key":"28139_CR8","doi-asserted-by":"publisher","first-page":"13614","DOI":"10.1073\/pnas.1320645111","volume":"111","author":"MF Dahlstrom","year":"2014","unstructured":"Dahlstrom MF. Using narratives and storytelling to communicate science with nonexpert audiences. Proc Natl Acad Sci U S A. 2014;111(Suppl 4):13614\u201320.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"28139_CR9","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1108\/09654281011068531","volume":"110","author":"J Zeelen","year":"2010","unstructured":"Zeelen J, Metseagharun T, Boersma M, Jansen W. Beyond silence and rumor: Storytelling as an educational tool to reduce the stigma around HIV\/AIDS in South Africa. Health Educ. 2010;110(5):382\u201398.","journal-title":"Health Educ"},{"issue":"9","key":"28139_CR10","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1016\/j.pec.2020.03.026","volume":"103","author":"JM Alber","year":"2020","unstructured":"Alber JM, Cohen C, Racho R, Freeland C, Ghazvini S, Tolentino B, Almeida R, Silliman M. Exploring the impact of storytelling on storytellers in a hepatitis B health communication context. Patient Educ Couns. 2020;103(9):1760\u20136. https:\/\/doi.org\/10.1016\/j.pec.2020.03.026.","journal-title":"Patient Educ Couns"},{"issue":"9","key":"28139_CR11","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1177\/1049732305276687","volume":"15","author":"HF Hsieh","year":"2005","unstructured":"Hsieh HF, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. 2005;15(9):1277\u201388. https:\/\/doi.org\/10.1177\/1049732305276687.","journal-title":"Qual Health Res"},{"key":"28139_CR12","doi-asserted-by":"publisher","first-page":"1437502","DOI":"10.3389\/fpubh.2024.1437502","volume":"12","author":"F Borondy-Jenkins","year":"2024","unstructured":"Borondy-Jenkins F, Ansah B, Chen J, Goldring A, Ibrahim Y, Issa S, Lesidrenska S, Machado T, Moore H, Njouom R, Okinedo P, Racho R, Scott L, Zovich B, Cohen C. Global hepatitis B and D community advisory board: expectations, challenges, and lessons learned. Front Public Health. 2024;12:1437502. https:\/\/doi.org\/10.3389\/fpubh.2024.1437502.","journal-title":"Front Public Health"},{"key":"28139_CR13","doi-asserted-by":"publisher","first-page":"18","DOI":"10.7812\/TPP\/18-052","volume":"23","author":"EL Pallai","year":"2019","unstructured":"Pallai EL, Tran K. Narrative health: using story to explore definitions of health and address bias in health care. Perm J. 2019;23:18\u2013052. https:\/\/doi.org\/10.7812\/TPP\/18-052.","journal-title":"Perm J"},{"issue":"4","key":"28139_CR14","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1080\/01973533.2022.2039657","volume":"44","author":"J Zhuang","year":"2022","unstructured":"Zhuang J, Guidry A. Does storytelling reduce stigma? A meta-analytic view of narrative persuasion on stigma reduction. Basic Appl Soc Psychol. 2022;44(4):25\u201337. https:\/\/doi.org\/10.1080\/01973533.2022.2039657.","journal-title":"Basic Appl Soc Psychol"},{"issue":"7","key":"28139_CR15","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1080\/10410236.2019.1598614","volume":"35","author":"K Heley","year":"2020","unstructured":"Heley K, Kennedy-Hendricks A, Niederdeppe J, Barry CL. Reducing health-related stigma through narrative messages. Health Commun. 2020;35(7):849\u201360. https:\/\/doi.org\/10.1080\/10410236.2019.1598614.","journal-title":"Health Commun"},{"key":"28139_CR16","volume-title":"Stigma: notes on the management of spoiled identity","author":"E Goffman","year":"1963","unstructured":"Goffman E. Stigma: notes on the management of spoiled identity. New York: Simon & Schuster; 1963."},{"key":"28139_CR17","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/978-1-4615-4193-6_2","volume-title":"Handbook of Community Psychology","author":"MA Zimmerman","year":"2000","unstructured":"Zimmerman MA. Empowerment theory: psychological, organizational and community levels of analysis. In: Rappaport J, Seidman E, editors. Handbook of Community Psychology. Boston (MA): Springer; 2000. pp. 43\u201363."},{"issue":"3","key":"28139_CR18","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.pec.2011.03.004","volume":"85","author":"M Heisler","year":"2011","unstructured":"Heisler M. Actively engaging patients through storytelling to enhance health outcomes. Patient Educ Couns. 2011;85(3):e1\u20132. https:\/\/doi.org\/10.1016\/j.pec.2011.03.004.","journal-title":"Patient Educ Couns"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-026-28139-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-026-28139-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-026-28139-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:45:46Z","timestamp":1793943946000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-026-28139-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["28139"],"URL":"https:\/\/doi.org\/10.1186\/s12889-026-28139-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-9419489\/v1","asserted-by":"object"}]},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]},"assertion":[{"value":"14 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Heartland Institutional Review Board (HIRB 070925\u2009\u2212\u20091229). No identifiable information was included, and all participants provided informed consent prior to study participation and informed that they may withdraw at any time. Confidentiality was maintained throughout the study, and participation was voluntary. Researchers maintain awareness of pre-existing relationships with participants and mitigate bias by emphasizing the voluntary nature of participation. This study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"In the past 36 months, the Hepatitis B Foundation has received outreach and public health grants from BMS, GSK, Gilead Sciences, Grifols, Aligos, nChroma, Precision Biosciences, Mirum, Vir Biotechnology, Roche, and Exact Sciences. Bright Ansah reports on involvement in projects that have received funding from pharmaceutical companies, including GSK.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"3250"}}